Late-Onset Rash Associated with Lamotrigine: Case Report
DOI:
https://doi.org/10.25752/psi.6070Keywords:
lamotrigine, bipolar disorder, Rash, Late-onset rashAbstract
The use of lamotrigine in Bipolar Disorder has been approved by the F.D.A since 2003. Rash is the more frequent adverse effect related to the treatment with Lamotrigine and in several cases is the cause for discontinuation of medical treatment. The less frequent related cases of rash are the late onset ones. About a women’s case with a late onset of rash, we revised the clinical use of Lamotrigine in Bipolar Disorder published bibliography which is followed by a special focus in the rash itself and finally we present some particular issues about late onset rash.
Downloads
Published
Issue
Section
License
Articles are published under the license CC-BY-3.0 by Creative Commons, in full open-access, without any cost or fees of any kind to the author or the reader. In this scheme, the authors retain copyright and grant the journal right of first publication, allowing the free sharing of work, provided it is correctly attributed the authorship and initial publication in this journal. Readers and end-users are allowed to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship. The authors are permitted to take on additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, post it to an institutional repository or as a book), with an acknowledgment of its initial publication in this journal. Authors are permitted and encouraged to publish and distribute their work online (eg, in institutional repositories or on their website) as it can lead to productive exchanges, as well as increase the impact and citation of published work.
